2019 top news stories
Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first...
Read More...
Focus:
-
Deals this week: Voyager Therapeutics, Pulmatrix, Horizon Discovery
Voyager Therapeutics will develop and commercialise Neurocrine Biosciences' gene therapy candidates used to treat severe neurological...
Read More...
-
Deals this week: PeptiDream, Proteus Digital Health, Novartis
PeptiDream has entered an agreement with Shionogi for identifying and developing a series of blood-brain...
Read More...
-
Deals this week: Ferring Pharmaceuticals, Mirati, Juvenescence
Ferring Pharmaceuticals (US) has entered an exclusive agreement with Sun Pharmaceutical Industries to acquire the...
Read More...
-
Deals this week: Keros Therapeutics, Opollomics, CANbridge
Keros Therapeutics has raised $23m in series B funding round.
Read More...
-
Deals this week: Antengene Corporation, Acer Therapeutics, Menarini
Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital...
Read More...
-
Deals this week: DelSiTech, Marken, Erasca
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV)...
Read More...
-
Deals this week: Moderna, Oxford Biotherapeutics, CBT Pharmaceuticals
Moderna has priced its initial public offering (IPO) of 26 million common stock shares priced...
Read More...
-
Deals this week: Argenx, SmartZyme BioPharma, Viracta Therapeutics
Argenx will develop and license its cancer drug candidate cusatuzumab (ARGX-110) after partnering with Janssen Pharmaceutical’s affiliate...
Read More...
-
Deals this week: Nuformix, Fluidic Analytics, F2G Biotech
Nuformix has expanded its agreement with Newsummit Biopharma (NSB) for the licensing and commercialisation of...
Read More...